Sign in to continue:

Wednesday, March 4th, 2026

Horizon Technology Finance Corp 2025 10-K: Key Investments, Cybersecurity Oversight, and Portfolio Details

Executive Summary

Horizon Technology Finance Corp (“Horizon” or “the Company”) has released its Annual Report for the fiscal year ending December 31, 2025. The 10-K filing provides comprehensive details on the Company’s financial position, cybersecurity practices, investment portfolio, capital structure, and governance. Below, we break down the most critical, potentially price-sensitive information for current and prospective shareholders.

Key Financial Highlights

  • Common Stock Activity:

    • Shares issued as of December 31, 2025: 45,781,280 (up from 40,043,312 in 2024).
    • Shares outstanding as of December 31, 2025: 45,613,815 (up from 39,875,847 in 2024).
    • Significant increase in shares outstanding driven by continuous public offerings, distribution reinvestment, and conversions of convertible notes.
  • Preferred Stock:

    • 1,000,000 shares authorized, none issued or outstanding.
  • Investment Portfolio:

    • Total investments at cost (unaffiliated issuers): \$616.2 million as of end-2025 (down from \$694.5 million in 2024).
    • Total investments at cost (affiliated issuers): \$89.0 million as of end-2025 (up from \$27.5 million in 2024).
    • Substantial portfolio exposure to Life Sciences, Technology, Healthcare, and Sustainability segments.
  • Concentration by Sector (Percent of Net Assets):

    • Life Sciences: 85.2%
    • Technology: 63.3%
    • Healthcare Information & Services: 25.4%
    • Sustainability: 1.5%

    Note: These numbers suggest significant sector concentration risk, especially in Life Sciences and Technology.

  • Convertible Notes:

    • The 2030 and 2031 Convertible Notes have impacted the share count via conversion, though their hypothetical conversion was antidilutive to per-share results for 2025 and 2024.

Cybersecurity and Risk Management

  • Board Oversight and Management Involvement:

    • Cybersecurity risk is actively managed by the Company’s management and a dedicated Response Team.
    • Processes are in place for regular risk assessment, prevention, detection, mitigation, and remediation of cybersecurity incidents.
    • The Board (or committee) is regularly informed and involved in cybersecurity oversight.
  • Third-Party Oversight:

    • Horizon leverages the resources of Monroe, including the Head of IT, for additional expertise and support.
  • Disclosure:

    • No material impact from cybersecurity threats was reported for 2025, and none are expected to materially affect the Company in the near future.

Governance and Shareholder Matters

  • Insider Trading and Award Timing Policies:

    • Policies are in place to govern insider trading and the timing of equity awards in accordance with best practices and SEC guidelines.
    • No Rule 10b5-1 trading plans were adopted or terminated in 2025.
  • Senior Securities:

    • Details provided on outstanding senior securities and asset coverage ratios, which are important for debt investors and credit risk assessment.

Potentially Price-Sensitive Issues

  • Capital Structure Changes:

    • The sharp increase in common shares outstanding may impact earnings per share (EPS) calculations and could be dilutive to existing shareholders, depending on the use of proceeds and return on new capital raised.
    • Convertible note conversions and continuous equity offerings suggest ongoing capital needs or opportunities, which could affect future valuations and capital deployment strategy.
  • Sector Concentration Risk:

    • Very high exposure to Life Sciences and Technology could amplify volatility, especially if these sectors experience macroeconomic or regulatory headwinds.
  • Cybersecurity Management:

    • While no material incidents were reported, the increasing regulatory and operational focus on cyber risk highlights the importance of robust controls. Any future incidents could have reputational or financial consequences.
  • Portfolio Liquidity and Credit Quality:

    • The report notes various investments in unaffiliated and affiliated issuers, often in the form of term loans with varying interest rates (notably, several sustainability loans at 11.75%). Credit risk and the collectability of these assets are important ongoing considerations for investors.

Other Notable Information

  • Distribution and Dividend Policy:

    • Distributions are determined based on taxable income, which may differ from GAAP due to differences in income recognition, unrealized appreciation/depreciation, and spillover income. Final tax treatment is only determined after year-end.
  • Weighted Average Calculations:

    • Total return and other performance metrics are calculated in accordance with SEC and GAAP standards, but investors should review the footnotes for methodology differences that could impact comparability.

Conclusion

In summary, Horizon Technology Finance Corp’s 2025 Annual Report highlights a period of significant equity issuance, continued sector concentration in Life Sciences and Technology, and strong attention to cybersecurity and risk oversight. Shareholders should closely monitor the Company’s capital strategy, exposure to sector-specific risks, and the effects of continued share dilution. While no immediate red flags are noted, these developments can materially influence share price and should be considered in ongoing investment decisions.


Disclaimer: This article is based on the Company’s SEC filings and is provided for informational purposes only. It does not constitute investment advice. Investors should conduct their own due diligence and consult with professional advisers before making investment decisions. The information is believed to be accurate as of the date of the report but may be subject to change without notice. The author and publisher take no responsibility for any actions taken based on the information contained herein.

View Horizon Technology Finance Corp Historical chart here



Consolidated Financial Statements 2024: US GoldMining Inc. Annual Report and Key Financial Data

GoldMining Inc. Discloses Audited Financials, Management Commentary, and Issues Caution to Investors GoldMining Inc. Files Audited Financial Statements and Management Discussion for FY2025; Issues Caution on Preliminary Data GoldMining Inc. (Nasdaq: USGO), the parent...

NeuroPace RNS System: Innovative Brain-Responsive Neuromodulation for Drug-Resistant Epilepsy – Company Overview, Business Strategy, Clinical Data, and Intellectual Property 30

NeuroPace, Inc. 2025 Annual Report – Key Highlights for Investors NeuroPace, Inc. 2025 Annual Report – Key Highlights for Investors Overview NeuroPace, Inc. has released its Annual Report on Form 10-K for the fiscal...

XOMA Royalty Corp 2025-2026 Corporate Overview: Biotech Royalty Aggregator Strategy, Portfolio Growth, and Financial Highlights

XOMA Royalty Corp: 2025 Review and 2026 Investor Outlook XOMA Royalty Corp: 2025 Review and 2026 Investor Outlook Key Highlights from XOMA Royalty Corp’s Corporate Update Strategic Business Model: XOMA positions itself as a...

   Ad